144 related articles for article (PubMed ID: 6375077)
21. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
22. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
Björk P; Jönsson U; Andrén-Sandberg A
Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
24. Estramustine binding in rat, baboon and human prostate measured by high pressure liquid chromatography.
Kirdani RY; Corrales JJ; Høisaeter PA; Karr JP; Murphy GP; Sandberg AA
Steroids; 1981 May; 37(5):471-84. PubMed ID: 7256814
[TBL] [Abstract][Full Text] [Related]
25. Hormonal regulation of an estramustine-binding protein in the submaxillary gland of the rat.
Pousette A; Björk P; Carlström K
J Steroid Biochem; 1987 Jan; 26(1):31-4. PubMed ID: 3493389
[TBL] [Abstract][Full Text] [Related]
26. Effects of testosterone on estracyt localization in rat prostate.
Catane R; Mittelman A; Murphy GP; Sandberg AA
Oncology; 1980; 37(5):357-9. PubMed ID: 7443167
[TBL] [Abstract][Full Text] [Related]
27. Design of cytotoxic steroids for prostate cancer.
Petrow V; Padilla GM
Prostate; 1986; 9(2):169-82. PubMed ID: 3748896
[TBL] [Abstract][Full Text] [Related]
28. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
Peterson C; Forsgren B; Högberg B
Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672
[No Abstract] [Full Text] [Related]
29. The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate.
Högberg B; Björk P; Carlström K; Forsgren B; Gustafsson JA; Hökfelt T; Pousette A
Prog Clin Biol Res; 1979; 33():181-99. PubMed ID: 531044
[No Abstract] [Full Text] [Related]
30. Expression of an estramustine-binding associated protein in human lung cancer cell lines.
Bergh J; Björk P; Westlin JE; Nilsson S
Cancer Res; 1988 Aug; 48(16):4615-9. PubMed ID: 2840198
[TBL] [Abstract][Full Text] [Related]
31. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Estramustine binding protein (EBP) in rat dorsal prostate by means of high pressure liquid chromatography.
Yamanaka H; Yuasa H; Kosaku N; Bashirelahi N; Shida K
Endocrinol Jpn; 1982 Dec; 29(6):669-74. PubMed ID: 7183436
[TBL] [Abstract][Full Text] [Related]
33. Estracyt--mode of action and clinical experience.
Hedlund PO
Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
[No Abstract] [Full Text] [Related]
34. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
Daehlin L; Södergård R; Damber JE
Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
[TBL] [Abstract][Full Text] [Related]
35. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993
[TBL] [Abstract][Full Text] [Related]
36. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
Bergenheim AT; Gunnarsson PO; Edman K; von Schoultz E; Hariz MI; Henriksson R
Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
[TBL] [Abstract][Full Text] [Related]
37. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
Kadohama N; Kirdani RY; Madajewicz S; Murphy GP; Sandberg AA
N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
[No Abstract] [Full Text] [Related]
38. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
Nilsson I; Liskowski L; Nilsson T
Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
[TBL] [Abstract][Full Text] [Related]
39. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
Høisaeter PA
Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
[No Abstract] [Full Text] [Related]
40. A comparative study of estramustine and pregnenolone binding to prostatic binding protein: evidence for subunit cooperativity.
Heyns W; Bossyns D
J Steroid Biochem; 1983 Dec; 19(6):1689-94. PubMed ID: 6686985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
